By Aakanksha Ahuja
DocPrime received an initial internal funding of $50 million from parent company PolicyBazaar Group in September this year.
PharmEasy, 1mg, Netmeds and LifCare, are racing ahead of the pack by raising large sums of capital and putting pressure on their peers to either keep raising cash or sell out.
The funds were raised through the issue of non-convertible debentures.
Vivriti Capital received approval from the Reserve Bank of India to float an NBFC in January 2018.
Existing investors Kalaari Capital, Unilever Ventures and Beenext Pte Ltd also participated in the round.
Fintech firm MobiKwik has raised $3.4 million in a fresh round of funding led by existing investor Sequoia Capital India.
Existing venture capital investors of Toppr—Eight Roads Ventures, Helion Ventures and SAIF Partners—also participated in the round.
Earlier, Bansal would have received cash from Walmart for over half of his 4-4.5% Flipkart stake worth over $850 million after August 2020.
The US private-equity firm is considering buying Punjab National Bank’s shares in PNB Housing, which would give it a controlling stake.
Venture Highway, Shailesh Rao and Innoven Capital also took part in the financing round. Till date, Moglix has raised $41 million in funding.